Stocks / Biotech

MRNABiotech

Moderna, Inc.
$159.171d +8.6%5d +17.5%settled close · 2026-09-17
Mkt cap $20B (3/25)β 1.8852w $22–166Shares 394.9MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2018Emp. 4,700HQ Cambridge, MAmodernatx.com
The tape, with the calls on it

Who said what, and what MRNA did next

Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.

bullish bearish both sides
Who’s talkingIdea Scout · free

Who’s talking about MRNA

1 shortlatest 2026-08-29
DateVoiceStanceVenueThesis
2026-08-29David FreebergCEO & Co-Founder, Ohalo GeneticsBearishAll-In PodcastModerna's mRNA cancer vaccine moat is weaker than the tripling market cap implies — the neo-antigen…
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 4 Nov 2026 before the open

Confirmed date · consensus EPS -1.32. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where MRNA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 13 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-08-25
2026-08-21
2026-08-20
2026-08-19
2026-08-06
2026-06-17
2026-06-16
2026-06-04
2026-05-07
2026-04-17
2026-04-10
2026-04-02
2026-03-27
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on MRNA is in this morning’s Brief. Get The Brief — $20/mo →